1,561
Participants
Start Date
September 30, 2014
Primary Completion Date
December 31, 2014
Study Completion Date
December 31, 2014
TIVc_LOT A
Single IM (Intramuscular) administration dose of 0.5 mL of TIVc
TIVc_LOT B
Single IM administration dose of 0.5 mL of TIVc
TIVc_LOT C
Single IM administration dose of 0.5 mL of TIVc
TIVf
Single IM administration dose of 0.5 mL of TIVf
Anaheim Clincial Trials, Anaheim
Northern California Clinical Research Center, Redding
Southern California CRC, San Diego
Broward Research Group, Hollywood
Comprehensive Clinical Trials, LLC, West Palm Beach
Palm Bech Research, West Palm Beach
Meridian Clinical Research, Savannah
Johnson County Clin-Trials, LLC, Lenexa
Heartland Research Associates, LLC, Wichita
Milford Emergency Associate,Inc, Milford
Meridian Clinical Research, Omaha
Rochester Clinical Research, Inc, Rochester
PMG Research of Charlotte, Charlotte
PMG Research of Hickory, Hickory
PMG Research of Raleigh, Raleigh
New Horizons Clinical Research, Cincinnati
Columbia Research Group, Inc, Portland
Omega Medical Research, Warwick
Clinical Research Solutions, LLC, Franklin
Clinical Research Associates, Inc, Nashville
Foothill Family Clinc South, J. Lewis Research Inc., Salt Lake City
Foothill Family Clinic, J. Lewis Research Inc., Salt Lake City
Jordan River Family Medicine, J. Lewis Research, Inc., South Jordan
Clinical Research Associates, Norfolk
Lead Sponsor
Novartis Vaccines
INDUSTRY